Annual Current Liabilities
$4.08 M
-$10.61 M-72.20%
31 December 2023
Summary:
Finch Therapeutics annual total current liabilities is currently $4.08 million, with the most recent change of -$10.61 million (-72.20%) on 31 December 2023. During the last 3 years, it has fallen by -$7.40 million (-64.44%). FNCH annual current liabilities is now -72.39% below its all-time high of $14.79 million, reached on 31 December 2021.FNCH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$4.46 M
+$963.00 K+27.52%
30 June 2024
Summary:
Finch Therapeutics quarterly total current liabilities is currently $4.46 million, with the most recent change of +$963.00 thousand (+27.52%) on 30 June 2024. Over the past year, it has dropped by -$417.00 thousand (-8.55%). FNCH quarterly current liabilities is now -73.42% below its all-time high of $16.79 million, reached on 31 March 2022.FNCH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.2% | -8.6% |
| 3 y3 years | -64.4% | -49.6% |
| 5 y5 years | - | - |
FNCH Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.4% | at low | -73.4% | +27.5% |
| 5 y | 5 years | -72.4% | at low | -73.4% | +27.5% |
| alltime | all time | -72.4% | at low | -73.4% | +27.5% |
Finch Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $4.46 M(+27.5%) |
| Mar 2024 | - | $3.50 M(-14.3%) |
| Dec 2023 | $4.08 M(-72.2%) | $4.08 M(-16.3%) |
| Sept 2023 | - | $4.88 M(-49.0%) |
| June 2023 | - | $9.57 M(-27.5%) |
| Mar 2023 | - | $13.21 M(-10.1%) |
| Dec 2022 | $14.69 M | $14.69 M(+6.4%) |
| Sept 2022 | - | $13.81 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $15.18 M(-9.6%) |
| Mar 2022 | - | $16.79 M(+13.5%) |
| Dec 2021 | $14.79 M(+28.8%) | $14.79 M(+67.1%) |
| Sept 2021 | - | $8.85 M(-7.1%) |
| June 2021 | - | $9.52 M(-17.2%) |
| Mar 2021 | - | $11.50 M(+0.1%) |
| Dec 2020 | $11.49 M(+56.8%) | $11.49 M |
| Dec 2019 | $7.33 M | - |
FAQ
- What is Finch Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Finch Therapeutics?
- What is Finch Therapeutics annual current liabilities year-on-year change?
- What is Finch Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Finch Therapeutics?
- What is Finch Therapeutics quarterly current liabilities year-on-year change?
What is Finch Therapeutics annual total current liabilities?
The current annual current liabilities of FNCH is $4.08 M
What is the all time high annual current liabilities for Finch Therapeutics?
Finch Therapeutics all-time high annual total current liabilities is $14.79 M
What is Finch Therapeutics annual current liabilities year-on-year change?
Over the past year, FNCH annual total current liabilities has changed by -$10.61 M (-72.20%)
What is Finch Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of FNCH is $4.46 M
What is the all time high quarterly current liabilities for Finch Therapeutics?
Finch Therapeutics all-time high quarterly total current liabilities is $16.79 M
What is Finch Therapeutics quarterly current liabilities year-on-year change?
Over the past year, FNCH quarterly total current liabilities has changed by -$417.00 K (-8.55%)